18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
Patient Recruiter Convicted in $1.3 Million Kickback Conspiracy Scheme - After a six-day trial, a ...
Read More >
As we previously reported, Connecticut has enacted the Time’s Up Act (the “Act”), which expanded ...
Read More >
It is often taken for granted that only the named parties to a contract can enforce it. The English ...
Read More >
On May 26, 2020, the Court of Appeals of Maryland (Maryland’s highest court) held that where one of...
Read More >
The New York Department of Environmental Conservation (NYDEC) announced last week that it will not b...
Read More >
The Supreme Court in Intel Corporation Investment Policy Committee et al. v. Sulyma, case No. 18–11...
Read More >